ARRY
Price
$7.15
Change
-$0.01 (-0.14%)
Updated
Jan 17 closing price
Capitalization
2.22B
51 days until earnings call
MREO
Price
$2.86
Change
-$0.04 (-1.38%)
Updated
Jan 17 closing price
Capitalization
443.72M
67 days until earnings call
Ad is loading...

ARRY vs MREO

Header iconARRY vs MREO Comparison
Open Charts ARRY vs MREOBanner chart's image
Array Technologies
Price$7.15
Change-$0.01 (-0.14%)
Volume$6.04M
Capitalization2.22B
Mereo BioPharma Group
Price$2.86
Change-$0.04 (-1.38%)
Volume$1.17M
Capitalization443.72M
ARRY vs MREO Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. MREO commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and MREO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MREO: $2.86)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green while.

  • MREO’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 4 bearish.
  • MREO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ARRY and MREO are a good buy in the short-term.

Price Growth

MREO (@Biotechnology) experienced а -19.44% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

MREO is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than MREO($444M). ARRY YTD gains are higher at: 18.377 vs. MREO (-18.286). ARRY has higher annual earnings (EBITDA): 276M vs. MREO (-43.41M). ARRY has more cash in the bank: 249M vs. MREO (80.5M). MREO has less debt than ARRY: MREO (6.68M) vs ARRY (730M). ARRY has higher revenues than MREO: ARRY (1.58B) vs MREO (1M).
ARRYMREOARRY / MREO
Capitalization2.22B444M500%
EBITDA276M-43.41M-636%
Gain YTD18.377-18.286-101%
P/E Ratio26.23N/A-
Revenue1.58B1M157,700%
Total Cash249M80.5M309%
Total Debt730M6.68M10,927%
FUNDAMENTALS RATINGS
ARRY: Fundamental Ratings
ARRY
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARRYMREO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
83%
MACD
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 11 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 11 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOUX22.280.19
+0.86%
Goldman Sachs Mid Cap Growth R6
OIEPX24.220.16
+0.67%
JPMorgan Equity Income R3
WDIAX13.650.09
+0.66%
Wilmington Enhanced Div Inc Strat A
FVDFX36.740.17
+0.46%
Fidelity Value Discovery
HULEX33.680.09
+0.27%
Huber Select Large Cap Value Instl

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
-0.14%
SHLS - ARRY
66%
Closely correlated
-0.86%
FSLR - ARRY
61%
Loosely correlated
+1.04%
NXT - ARRY
59%
Loosely correlated
-2.39%
RUN - ARRY
57%
Loosely correlated
-1.15%
AXON - ARRY
53%
Loosely correlated
+1.37%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-1.38%
MDGL - MREO
37%
Loosely correlated
+7.64%
TERN - MREO
36%
Loosely correlated
-1.56%
INZY - MREO
33%
Loosely correlated
N/A
XERS - MREO
31%
Poorly correlated
-0.62%
ARRY - MREO
30%
Poorly correlated
-0.14%
More